This bill would make some extra biosimilar drug studies optional instead of routine. Federal health officials could still require them, but they would have to give the company written reasons early in the process.
Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Expedited Access to Biosimilars Act is a Senate bill waiting for floor action. The latest recorded action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 520.
Latest action on S. 1414: Placed on Senate Legislative Calendar under General Orders. Calendar No. 520.
Who this affects: This bill mainly affects companies that develop biosimilars and the Food and Drug Administration staff who review them. Patients and health plans could also feel the effects if the change helps more biosimilars reach the market. The bill would apply only to future biosimilar applications filed after it becomes law.
Why this matters: Biosimilars can give patients more choices for costly biologic medicines, and this bill could make some of them easier to bring to market. It may reduce testing costs for drug makers. It may also speed up some applications. The safety tradeoff depends on how often FDA leaders still require extra studies for immune reactions or other important differences.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
Officially: Expedited Access to Biosimilars Act
This bill would make some extra biosimilar drug studies optional instead of routine. Federal health officials could still require them, but they would have to give the company written reasons early in the process.
Use this page to support, oppose, or ask Congress to amend S1414. Modern Action explains what the bill does, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
floor_pending
Your representatives are deciding where they stand. A few messages can tip the balance.
↓ Why your message matters here
This bill is moving through Congress right now — your representative needs to hear from you.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in Senate
Senate Committee
Under Senate committee consideration
Senate Floor Vote
Voted on by Senate
Latest: Placed on Senate Legislative Calendar under General Orders. Calendar No. 520. (7/27/2026)
Passed Senate
Approved by Senate
House Review
Sent to House for consideration
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your senators when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to Expedited Access to Biosimilars Act, then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it does, where it is in the process (floor pending), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around S1414, your stance, and the reasons you choose, then lets you edit and send when ready.
